Yüklüyor......
Glycoprotein IIb/IIIa inhibitors and low‐molecular‐weight heparins: A combined role in coronary interventions?
Management strategies for acute coronary syndromes (ACS) are making increasing use of both low‐molecular‐weight heparins (LMWHs) and glycoprotein (GP) IIb/IIIa inhibitors. To date, however, relatively few studies have assessed the clinical potential of these two classes of agents in combination. The...
Kaydedildi:
| Yayımlandı: | Clin Cardiol |
|---|---|
| Yazar: | |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Wiley Periodicals, Inc.
2009
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6654834/ https://ncbi.nlm.nih.gov/pubmed/11286313 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/clc.4960241304 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|